share_log

4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II

SEC ·  Jul 3 05:30
Summary by Futu AI
In a recent transaction, Theodore R. II Samuels, a reporting person for Bristol-Myers Squibb (BMY), engaged in a stock market action on June 30, 2024. Specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Samuels' position and the potential implications for Bristol-Myers Squibb's stock.
In a recent transaction, Theodore R. II Samuels, a reporting person for Bristol-Myers Squibb (BMY), engaged in a stock market action on June 30, 2024. Specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The absence of this information leaves a gap in understanding the full impact of the transaction on Samuels' position and the potential implications for Bristol-Myers Squibb's stock.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.